3 results match your criteria: "Oregon Health and Science University Epilepsy Center[Affiliation]"
Epilepsy Behav
May 2007
Oregon Health and Science University Epilepsy Center, 3181 SW Sam Jackson Park Road, CDW-3, Portland, OR 97201, USA.
Objective: Previous quantitative EEG (QEEG) studies of carbamazepine (CBZ), oxcarbazepine (OXC), and phenytoin (PHT) revealed a pattern of EEG slowing and an increase in drowsiness on the awake maintenance task (AMT). EEG slowing has been shown to correlate with negative effects on cognitive tests. Topiramate (TPM) is a novel AED with relatively large negative effects on cognitive function.
View Article and Find Full Text PDFEpilepsia
August 2003
Oregon Health and Science University Epilepsy Center, Portland, Or 97239, USA.
Purpose: Antiepileptic drugs (AEDs) can be associated with adverse neurologic effects including cognitive dysfunction. Objective methods for recognizing AED effects on the brain could be valuable for long-term management. We compared quantitative EEG measures and cognitive tests in a group of patients beginning or ending AED therapy.
View Article and Find Full Text PDFCurr Treat Options Neurol
March 2003
Oregon Health and Science University Epilepsy Center, 3181 SW Sam Jackson Park Road, CDW-3, Portland, OR 97239, USA.
Vagus nerve stimulation is a unique therapy for epileptic seizures. Two randomized controlled trials in patients with medically refractory partial seizures have demonstrated efficacy, leading to US Food and Drug Administration approval of vagus nerve stimulation therapy in 1997. Extensive safety testing has not revealed significant effects on cardiac, respiratory, or gastrointestinal function, though recent reports of intraoperative asystole and sleep-related airway obstruction have raised concerns.
View Article and Find Full Text PDF